Prognostic Value of Immune-Related Genes in the Tumor Microenvironment of Bladder Cancer

Faping Li,Haolin Teng,Mingdi Liu,Bin Liu,Difei Zhang,Zhixiang Xu,Yishu Wang,Honglan Zhou
DOI: https://doi.org/10.3389/fonc.2020.01302
IF: 4.7
2020-07-28
Frontiers in Oncology
Abstract:The tumor microenvironment (TME) is a complex system that plays an important role in tumor development and progression, but the current knowledge about its effect on bladder cancer (BC) is scarce. In this study, we performed a comprehensive analysis of the relationship between the TME and gene expression profiles to identify prognostic biomarkers for BC. The ESTIMATE algorithm was used to calculate immune and stromal scores of BC patients who were obtained from the Gene Expression Omnibus database. We found that the immune and stromal scores were associated with clinical characteristics and the prognosis of BC patients. Based on these scores, 104 immune-related differentially expressed genes were identified. Further, functional enrichment analysis revealed that these genes were mainly involved in the immune-related biological processes and signaling pathways. Three prognostic genes were then identified and used to establish a risk prediction model using Cox regression analyses. Kaplan–Meier survival analysis showed that the expression levels of COL1A1, COMP, and SERPINE2 significantly correlated with cancer-specific survival and overall survival of BC patients. Additionally, we validated the prognostic values of these genes using two independent cohorts from The Cancer Genome Atlas and Gene Expression Omnibus databases. Finally, the relationships between the three prognostic genes and several immune cells were evaluated using Tumor Immune Estimation Resource, indicating that the expression levels of COL1A1, COMP, and SERPINE2 correlated positively with the tumor infiltration levels of CD4<sup>+</sup> T cells and macrophages. In conclusion, the current study comprehensively analyzed the TME and presented immune-related prognostic genes for BC, providing new insights into immunotherapeutic strategies for BC patients.
oncology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the prognostic value of immune - related genes in the tumor microenvironment (TME) of bladder cancer (BC). Specifically, by analyzing the relationship between TME and gene expression profiles, the researchers aim to identify biomarkers that can be used for BC prognosis. The main objectives of the paper include: 1. **Evaluate the relationship between TME and BC clinical features and prognosis**: Use the ESTIMATE algorithm to calculate the immune score and stromal score of BC patients, and explore the associations between these scores and clinical features (such as invasiveness, histological grade, and stage) and patient prognosis. 2. **Identify differentially expressed immune - related genes**: Based on the immune score and stromal score, identify immune - related genes that are differentially expressed between the high - score group and the low - score group. 3. **Establish a prognostic risk prediction model**: Through Cox regression analysis, screen out genes that are significantly associated with cancer - specific survival (CSS) from the differentially expressed genes, and establish a risk prediction model containing these genes. 4. **Verify the reliability of prognostic genes**: Use independent data sets (such as data in the TCGA and GEO databases) to verify the reliability and usability of the identified prognostic genes. 5. **Explore the relationship between prognostic genes and immune cell infiltration**: Use the Tumor Immune Estimation Resource (TIMER) tool to evaluate the relationship between prognostic genes and the infiltration levels of different immune cells (such as CD4+ T cells and macrophages). ### Main findings - **Relationship between immune and stromal scores and BC clinical features and prognosis**: - Immune and stromal scores are significantly associated with the invasiveness, histological grade, and stage of BC. - High immune and stromal scores are associated with poorer cancer - specific survival (CSS), but not significantly associated with overall survival (OS). - **Differentially expressed immune - related genes**: - By comparing the high - score group and the low - score group, 104 immune - related differentially expressed genes are identified. - These genes are mainly involved in biological processes such as extracellular matrix organization, inflammatory response, and immune response. - **Prognostic risk prediction model**: - Through Cox regression analysis, three key prognostic genes, COL1A1, COMP, and SERPINE2, are screened out. - The established risk prediction model shows that high - risk scores are significantly associated with poorer CSS and OS. - **Verification of prognostic genes**: - The prognostic values of COL1A1, COMP, and SERPINE2 are verified using independent data sets in the TCGA and GEO databases. - The results show that the high expression of these genes is significantly associated with poorer prognosis. - **Relationship between prognostic genes and immune cell infiltration**: - The expression levels of COL1A1, COMP, and SERPINE2 are positively correlated with the infiltration levels of multiple immune cells (such as CD4+ T cells and macrophages). ### Conclusion This study comprehensively analyzes the TME of BC, identifies immune genes related to prognosis, and provides new insights into the immunotherapy strategies for BC patients. These findings contribute to a better understanding of the molecular mechanisms of BC and may provide new targets for early diagnosis and effective treatment.